M D Anderson Cancer Center
Houston, Texas, 77030, United States
NCT Number: NCT05763797
To determine the feasibility of implementing a culturally adapted mind-body intervention (Meditation-Based Support-Adapted; MBS-A) as a supportive care strategy in Black patients diagnosed with a stage III-IV solid malignancy. To target the specific needs of Black advanced cancer patients, we will first conduct formative research that includes quantitative surveys and in-depth interviews of patients and their primary caregivers. The purpose of this formative research is to determine the intervention format for the MBS-A program (family- vs group-based) that promises the greatest likelihood of success and to solicit input on the original MBS intervention regarding content that needs adaptation. Once the intervention format is determined and content adapted, we will conduct a pilot randomized controlled trial (RCT) to examine the feasibility of the MBS-A intervention vs. a dose-matched attention control (AC) group receiving a psychoeducation intervention.
This study is active but is not currently recruiting participants.
Notify MePrimary Objectives:
The purpose of this RCT is to thoroughly determine the feasibility of the overall RCT design as well as specific intervention procedures in this underserved population to inform if a large efficacy trial is warranted. Our results will lead to future NIH R01 applications in which efficacy and mechanisms of the interventions will be tested using fully powered samples of Black patients with advanced cancer including multicenter trials. The long-term goal is to establish the effectiveness of the MBS-A intervention and widely disseminate the intervention. Ultimately, the intervention is intended to improve cancer control and reduce the double disparity in this underserved patient population.
We propose the following specific aims:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For Aim 1, in order to be eligible to participate in this study, a patient must meet all of the following criteria:
For Aims 2 and 3, in order to be eligible to participate in this study, a patient must meet all of the following criteria:
For Aims 2 and 3, if a family-based intervention is selected as the program format, a patient must meet the additional following criterion:
Also, if a family-based intervention is selected as the program format, a caregiver must meet all of the following criteria:
Exclusion criteria
For Aim 1, there are no exclusion criteria.
For Aims 2 and 3, a patient who meets any of the following criteria will be excluded from participation in this study:
Group 1, participant will be in a supportive care program with other Black cancer patients in which you will practice meditation.
Group 2, participate will be in a supportive care program with other Black cancer patients that focuses on coping with cancer.
Participants will be asked to participate weekly sessions for 4 weeks (that is a total of 4 sessions) and each session will last about 60 minutes. Both groups will be delivered via Zoom (a web-based videoconferencing service) and led by a master's-level interventionist.
Group 1, participant will be in a supportive care program with other Black cancer patients in which you will practice meditation.
Group 2, participate will be in a supportive care program with other Black cancer patients that focuses on coping with cancer.
Participants will be asked to participate weekly sessions for 4 weeks (that is a total of 4 sessions) and each session will last about 60 minutes. Both groups will be delivered via Zoom (a web-based videoconferencing service) and led by a master's-level interventionist.
Time frame: through study completion; an average of 1 year.
MD Anderson Symptom Inventory, which consists of 13 core items assessing symptom severity and 6 items assessing symptom interference with daily living.71,72 If the family-based format is selected, patients and caregivers will complete the form as it applies to their own symptoms as well as their perceptions of each other's symptoms.73
MD Anderson Symptom Inventory-Score Scale "at its worst" using 0-10 numerical rating scales with 0 = "not present" and 10 = "as bad as you can imagine."
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01169259
Cancer, Cardiovascular Disease
Boston, Massachusetts, United States
View Trial DetailsNCT07076004
Cancer, Neoplasms
New Haven, Connecticut, United States
View Trial DetailsNCT00339495
Cancer, Death
Rockville, Maryland, United States
View Trial DetailsNCT07729241
COVID-19, COVID-19 Vaccination
Paris, France
View Trial Details